NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Breast Cancer Vaccine



Killed Mycobacterium vaccae may augment efficacy of trastuzumab



March 24th, 2005

Killed Mycobacterium vaccae may augment the efficacy of trastuzumab in metastatic breast cancer patients.

"SRL172, non-specific immunological adjuvant downregulates interleukin (IL)-4, upregulates IL-2 production, switching towards a T-helper-1 response, induces an increase in natural killer cells and activates antigen presenting cells. The human epidermal growth factor receptor 2 gene amplification is frequently observed in a number of primary tumors, suggesting that the overexpression of this growth factor receptor may contribute to transformation and tumorigenesis. Gene amplification occurs in {{approx}}15-20% of human breast cancers. Amplification is...


Source: Women's Health Weekly (2005-03-24)

NewsRx Passes
Advertisement
More Articles

------------------------
Security by Verisign PR Login